Clinical and Laboratory Parameters of Myelodysplastic Syndromes at Upper Egypt

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06244173

Enrollment

100

Registered

2024-02-06

Start date

2017-06-01

Completion date

2023-12-01

Last updated

2024-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myelodysplastic Syndromes

Brief summary

The aim of our study is to assess clinical & laboratory parameters of adult Egyptian myelodysplastic syndrome patients in upper Egypt, its correlation with disease-free survival, overall survival (OS) and acute leukemia transformation.

Detailed description

The aim of this study is to assess clinical & laboratory parameters of adult Egyptian myelodysplastic syndrome patients in upper Egypt, its correlation with disease-free survival, overall survival (OS) and acute leukemia transformation. Materials and methods: This study will be conducted in Sohag University Hospital and Assuit University Hospitals on available number of newly diagnosed patients with MDS according to the diagnostic criteria proposed by the WHO in 2016 . full history taking, clinical assessment and certain laboratory investigations are conducted to every patient enrolled in this study.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* De novo MDS according to WHO criteria diagnosis 2016

Exclusion criteria

* MDS on top of AML

Design outcomes

Primary

Measure	Time frame	Description
overall survival	baseline	analysis of collected data

Countries

Egypt

Outcome results